Theragenics Corp. Securities LitigationTheragenics Corporation is a Delaware corporation with its headquarters in Buford, Georgia. It is in the business of producing and selling radioactive seed implants to treat prostate cancer, among other things.Plaintiffs’ Second Amended Complaint dated August 21, 2000 (the "Complaint") filed in the Action generally alleges, among other things, that Defendants issued false and misleading press releases and other statements regarding Theragenics’ financial condition during the Class Period between January 29, 1998 and January 11, 1999, inclusive, in order to artificially inflate the value of Theragenics common stock. The Complaint further alleges that Lead Plaintiffs and other Class Members purchased the common stock of Theragenics during the Class Period at prices artificially inflated as a result of the Defendants’ dissemination of materially false and misleading statements regarding Theragenics in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder. Defendants deny they did anything wrong and believe that Plaintiffs’ claims are meritless.
|
Having Trouble?Having trouble opening .pdf files?
FAQs |
